SLOT: Full Definition
What is compounded semaglutide?
Compounded semaglutide — sometimes called "compounded GLP-1" — is a version of the medication semaglutide prepared by a licensed compounding pharmacy rather than the FDA-approved branded products Ozempic and Wegovy. Compounding is the practice of customizing a medication for an individual patient's needs, typically when the commercial product is unavailable, when a different dose or formulation is required, or when a patient cannot tolerate certain inactive ingredients.
Compounded semaglutide became widely used during the 2022-2024 shortage of branded semaglutide, when the FDA temporarily allowed compounding pharmacies to fill the gap. As shortages have eased, the regulatory landscape has tightened, and patients should understand the differences before choosing this route.
How does compounded semaglutide work?
The active ingredient is the same molecule as branded semaglutide — a once-weekly Glp 1 Agonists that:
- Slows gastric emptying for greater meal satisfaction
- Reduces appetite and food preoccupation
- Stimulates glucose-dependent insulin release
- Lowers glucagon between meals
What differs is the manufacturing chain. FDA-approved semaglutide is produced under FDA-inspected manufacturing standards. Compounded semaglutide is produced by individual pharmacies under state board oversight and (for 503B outsourcing facilities) FDA oversight, but the raw ingredient sourcing, sterility testing, and final-product validation can vary significantly between pharmacies.
When is compounded semaglutide prescribed?
Compounded semaglutide is most appropriate when:
- The branded product is genuinely unavailable
- A patient needs a dose that the commercial product does not provide
- Insurance does not cover branded GLP-1 therapy and the cash price is prohibitive
At Modern Thyroid Clinic, we generally prefer FDA-approved products such as Wegovy or Zepbound when accessible, because the manufacturing chain, outcome data, and safety surveillance are more robust. We discuss compounded options transparently when branded therapy is not feasible.
Patient considerations
Key considerations include:
- Pharmacy quality matters enormously. Look for pharmacies that publish third-party sterility and potency testing.
- Salt forms vs. base semaglutide: only the base form is the same molecule as Ozempic/Wegovy. Some compounders have used salts (e.g., semaglutide sodium, semaglutide acetate) that the FDA has flagged as not interchangeable.
- Variable concentration and labeling can lead to dosing errors, especially when patients self-inject from multi-dose vials.
- No outcome data specific to compounded versions — the safety and efficacy data come from branded trials.
This is one area where shortcutting through a slick online clinic can lead to real harm. Always work with a clinician who can review pharmacy sourcing and monitor your response. As with any GLP-1 therapy, decisions should be individualized and made with a qualified provider.
Common symptoms
Common questions
Is compounded semaglutide the same as Ozempic or Wegovy?
Not exactly. The active molecule can be the same when the compounding pharmacy uses base semaglutide, but the manufacturing process, quality controls, sterility testing, and inactive ingredients differ. Some compounded products have used salt forms (semaglutide sodium or acetate) that the FDA does not consider equivalent to the FDA-approved branded versions. Outcome and safety data published in major trials apply specifically to the branded products. Compounded semaglutide is a reasonable bridge in some situations, but it is not interchangeable in the strictest regulatory or clinical sense.
Is compounded semaglutide safe?
It depends heavily on the pharmacy. Reputable 503B outsourcing facilities and 503A pharmacies that publish third-party potency and sterility testing can produce reliable products. Less reputable operations have produced inconsistent concentrations, contaminated products, or used non-equivalent salt forms. The FDA has issued multiple safety alerts during the shortage period. At Modern Thyroid Clinic we vet pharmacy sources carefully when compounded products are used and prefer FDA-approved [glp-1-agonists] when they are accessible. Always discuss the specific pharmacy with your clinician.
Why would someone use compounded semaglutide instead of Wegovy?
The main reasons are access and cost. During shortages, branded products were unavailable for months at a time, and many patients turned to compounded versions to maintain continuity of care. Even now, branded semaglutide and tirzepatide can cost $1,000-$1,400 per month without insurance, while compounded versions are often offered for $200-$400 monthly. For some women, compounded therapy is the only realistic path forward. The trade-off is lower regulatory oversight — which makes pharmacy selection and clinical monitoring particularly important.
Think you might be dealing with this?
Talk to a Modern Thyroid Clinic specialist about your symptoms, labs, and next steps.
Book a Discovery CallThis content is for educational purposes only and is not medical advice. Consult a licensed clinician for diagnosis and treatment. Content on this page does not create a doctor-patient relationship with Modern Thyroid Clinic.